These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 27178487)

  • 1. The effect of hyperlipidemia on the pharmacokinetics, hepatic and pulmonary uptake of posaconazole in rat.
    Khalil HA; Elnaggar MM; Belal TS; El-Yazbi AF; Hamdy DA
    Eur J Pharm Sci; 2016 Aug; 91():190-5. PubMed ID: 27178487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlipidemia Alters the Pharmacokinetics of Posaconazole and Vincristine Upon Co-Administration in Rats.
    Khalil HA; ElKhatib MAW; Belal TS; El-Yazbi AF; Hamdy DA
    Drugs R D; 2017 Jun; 17(2):287-296. PubMed ID: 28299646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of increased lipoproteins levels on the disposition of vincristine in rat.
    Khalil HA; Belal TS; El-Yazbi AF; Hamdy DA
    Lipids Health Dis; 2016 Sep; 15(1):152. PubMed ID: 27613245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hyperlipidemia on the pharmacokinetics of nifedipine in the rat.
    Eliot LA; Foster RT; Jamali F
    Pharm Res; 1999 Feb; 16(2):309-13. PubMed ID: 10100319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of human immunodeficiency virus protease inhibitor, nelfinavir, in poloxamer 407-induced hyperlipidemic model rats.
    Sugioka N; Haraya K; Maeda Y; Fukushima K; Takada K
    Biol Pharm Bull; 2009 Feb; 32(2):269-75. PubMed ID: 19182388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of dronedarone in normolipidemic and hyperlipidemic rats.
    Jardan YA; Brocks DR
    Biopharm Drug Dispos; 2016 Sep; 37(6):345-51. PubMed ID: 27194397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of experimental hyperlipidemia on the stereoselective tissue distribution, lipoprotein association and microsomal metabolism of (+/-)-halofantrine.
    Patel JP; Fleischer JG; Wasan KM; Brocks DR
    J Pharm Sci; 2009 Jul; 98(7):2516-28. PubMed ID: 18972574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hyperlipidemia on ketoconazole-midazolam drug-drug interaction in rat.
    Hamdy DA; Brocks DR
    J Pharm Sci; 2011 Nov; 100(11):4986-92. PubMed ID: 21698600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic alterations in poloxamer 407-induced hyperlipidemic rats.
    Lee U; Kwon MH; Kang HE
    Xenobiotica; 2019 May; 49(5):611-625. PubMed ID: 29658375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of increased lipoprotein levels on the pharmacokinetics of ketoconazole enantiomers in the rat.
    Hamdy DA; Brocks DR
    Xenobiotica; 2011 Feb; 41(2):137-43. PubMed ID: 21058917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posaconazole Tablets in Real-Life Lung Transplantation: Impact on Exposure, Drug-Drug Interactions, and Drug Management in Lung Transplant Patients, Including Those with Cystic Fibrosis.
    Launay M; Roux A; Beaumont L; Douvry B; Lecuyer L; Douez E; Picard C; Grenet D; Jullien V; Boussaud V; Guillemain R; Billaud EM
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of a cytochrome P450 2E1 probe, chlorzoxazone, and its 6-hydroxy metabolite in poloxamer 407-induced hyperlipidemic rats.
    Kwon MH; Lee CJ; Cho YY; Kang HE
    J Pharm Pharm Sci; 2013; 16(4):648-56. PubMed ID: 24210069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of increased lipoprotein levels on the pharmacokinetics of cyclosporine A in the laboratory rat.
    Brocks DR; Ala S; Aliabadi HM
    Biopharm Drug Dispos; 2006 Jan; 27(1):7-16. PubMed ID: 16278928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in brain distribution of fluvoxamine in experimental hyperlipidemic rats.
    Fukushima K; Kobuchi S; Shibata M; Takada K; Sugioka N
    J Pharm Pharm Sci; 2011; 14(3):414-24. PubMed ID: 22202224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of tolbutamide and its metabolite 4-hydroxy tolbutamide in poloxamer 407-induced hyperlipidemic rats.
    Choi MR; Kwon MH; Cho YY; Choi HD; Kim YC; Kang HE
    Biopharm Drug Dispos; 2014 Jul; 35(5):264-74. PubMed ID: 24590592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of serum lipoproteins on stereoselective halofantrine metabolism by rat hepatocytes.
    Patel JP; Hamdy DA; El-Kadi AO; Brocks DR
    Chirality; 2012 Jul; 24(7):558-65. PubMed ID: 22589120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat-meal rat models.
    Shayeganpour A; Jun AS; Brocks DR
    Biopharm Drug Dispos; 2005 Sep; 26(6):249-57. PubMed ID: 15968713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of experimental hyperlipidemia on the pharmacokinetics of tadalafil in rats.
    Lee JH; Oh JH; Lee YJ
    J Pharm Pharm Sci; 2012; 15(4):528-37. PubMed ID: 23106956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of posaconazole in koalas (Phascolarctos cinereus) after intravenous and oral administration.
    Gharibi S; Kimble B; Vogelnest L; Barnes J; Stadler CK; Govendir M
    J Vet Pharmacol Ther; 2017 Dec; 40(6):675-681. PubMed ID: 28455999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population Pharmacokinetics of Posaconazole in Immune-Compromised Children and Assessment of Target Attainment in Invasive Fungal Disease.
    McCann S; Sinha J; Wilson WS; McKinzie CJ; Garner LM; Gonzalez D
    Clin Pharmacokinet; 2023 Jul; 62(7):997-1009. PubMed ID: 37179512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.